<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0170172</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-16082</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Inflammatory diseases</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Metabolic disorders</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Enzymology</subject><subj-group><subject>Enzyme chemistry</subject><subj-group><subject>Cofactors (biochemistry)</subject><subj-group><subject>Coenzymes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Necrosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Necrosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>C-reactive proteins</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Effects of Coenzyme Q10 on Markers of Inflammation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhai</surname>
<given-names>Junya</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bo</surname>
<given-names>Yacong</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lu</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Chunli</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Lishi</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Nutrition, Food Safety and Toxicology, West China School of Public Health, Sichuan University. Chengdu, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Surgery, Shanghai Ninth People’s Hospital (North), Shanghai Jiaotong University School of Medicine, Shanghai, China</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>López Lluch</surname>
<given-names>Guillermo</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Universidad Pablo de Olavide, SPAIN</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> JZ.</p></list-item> <list-item><p><bold>Data curation:</bold> YL CL.</p></list-item> <list-item><p><bold>Formal analysis:</bold> JZ YB.</p></list-item> <list-item><p><bold>Investigation:</bold> JZ YB.</p></list-item> <list-item><p><bold>Methodology:</bold> JZ YB.</p></list-item> <list-item><p><bold>Project administration:</bold> LZ.</p></list-item> <list-item><p><bold>Software:</bold> YL.</p></list-item> <list-item><p><bold>Supervision:</bold> LZ.</p></list-item> <list-item><p><bold>Validation:</bold> YL.</p></list-item> <list-item><p><bold>Visualization:</bold> YB.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> JZ.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> YB YL CL LZ.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">lishizhang_56@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>1</issue>
<elocation-id>e0170172</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Zhai et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0170172"/>
<abstract>
<sec id="sec001">
<title>Background/Objective</title>
<p>Chronic inflammation contributes to the onset and development of metabolic diseases. Clinical evidence has suggested that coenzyme Q10 (CoQ10) has some effects on inflammatory markers. However, these results are equivocal. The aim of this systematic review was to assess the effects of CoQ10 on serum levels of inflammatory markers in people with metabolic diseases.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>Electronic databases were searched up to February 2016 for randomized controlled trials (RCTs). The outcome parameters were related to inflammatory factors, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and C reactive protein (CRP). RevMan software was used for meta-analysis. Meta-regression analysis, Egger line regression test and Begg rank correlation test were performed by STATA software.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Nine trials involving 428 subjects were included in this meta-analysis. The results showed that compared with control group, CoQ10 supplementation has significantly improved the serum level of CoQ10 by 1.17μg/ml [MD = 1.17, <italic>95% CI</italic> (0.47 to 1.87) μg/ml, <italic>I</italic><sup>2</sup> = 94%]. Meanwhile, it has significantly decreased TNF-α by 0.45 pg/ml [MD = -0.45, <italic>95% CI</italic> (-0.67 to -0.24) pg/ml, <italic>I</italic><sup>2</sup> = 0%]. No significant difference was observed between CoQ10 and placebo with regard to CRP [MD = -0.21, <italic>95% CI</italic> (-0.60 to 0.17) mg/L, <italic>I</italic><sup>2</sup> = 21%] and IL-6 [MD = -0.89, <italic>95% CI</italic> (-1.95 to 0.16) pg/ml, <italic>I</italic><sup>2</sup> = 84%].</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>CoQ10 supplementation may partly improve the process of inflammatory state. The effects of CoQ10 on inflammation should be further investigated by conducting larger sample size and well-defined trials of long enough duration.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The authors received no specific funding for this work.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>1. Introduction</title>
<p>Chronic, low-grade systematic inflammation is a common pathogenetic denominator in many diseases. The elevated pro-inflammatory factors, such as C reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)[<xref ref-type="bibr" rid="pone.0170172.ref001">1</xref>], play a central role in metabolic diseases, including obesity, type 2 diabetes (T2DM), metabolic syndrome (MS), cardiovascular disease[<xref ref-type="bibr" rid="pone.0170172.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0170172.ref003">3</xref>] (CVD) and nonalcoholic fatty liver disease (NAFLD)[<xref ref-type="bibr" rid="pone.0170172.ref004">4</xref>]. Anti-inflammatory agents, old drugs (salicylates, especially salsalate) and new compounds (essentially monoclonal antibodies), are emerging in clinical management of the related chronic inflammatory diseases but the observed improvements appear rather modest, and questions have been remained in poorly known long-term safety and high cost [<xref ref-type="bibr" rid="pone.0170172.ref005">5</xref>]. Therefore, it is essential to find natural compounds for substitutions.</p>
<p>Coenzyme Q10 (CoQ10, ubiquinone-10) is an endogenously synthesized compound that acts as an essential cofactor in the mitochondrial electron transport system, a potent antioxidant of lipid membranes[<xref ref-type="bibr" rid="pone.0170172.ref006">6</xref>] and a modulator of the gene expression[<xref ref-type="bibr" rid="pone.0170172.ref007">7</xref>]. These functions underlie the rationale for its use in clinical practice and food supplement. Previous study reported CoQ10 tends to decrease hepatic mRNA expression of IL-6 and TNF-α[<xref ref-type="bibr" rid="pone.0170172.ref008">8</xref>], to attenuate the level of CRP[<xref ref-type="bibr" rid="pone.0170172.ref009">9</xref>]. Several randomized controlled trials (RCTs) demonstrated the efficacy of CoQ10 as an adjuvant therapeutic in metabolic diseases. However, the results of these trials are inconsistent, because of small sample sizes and uneven quality. Therefore, a meta-analysis of RCTs was conducted here to explore whether the supplementation of CoQ10 exhibits anti-inflammatory benefits.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>2. Materials and Methods</title>
<p>The meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Guidelines (<xref ref-type="supplementary-material" rid="pone.0170172.s001">S1 Checklist</xref>).</p>
<sec id="sec007">
<title>2.1 Search strategy</title>
<p>Systematic search was conducted in the PubMed, MEDLINE, Web of Science, Cochrane Library Databases (up to February 2016) for identifying eligible studies. The following combination of search terms was used in databases in English: (Coenzyme Q10 OR CoQ10 OR ubiquinone-10) AND (inflammation OR system inflammation OR IL-6 OR interleukin-6, OR CRP OR C reactive protein OR high sensitive CRP OR hs-CRP OR TNF-α OR tumor necrosis factor).</p>
</sec>
<sec id="sec008">
<title>2.2 Data selection</title>
<p>All titles and abstracts were independently screened by 2 investigators (JZ, YB) to evaluate eligibility for inclusion until consensus was reached. For a study to be included in the systematic review, it had to be: (1) RCTs; (2) participants aged 18 years or older; (3) intervention with capsule of CoQ10; (4) having a control group with placebo; (5) minimum intervention period of four weeks; (6) assessment markers of inflammation (CRP, IL-6, TNF-α); (7) data with normal distribution and report of mean and standard deviation (SD) or available data (standard errors, 95% confidence interval, <italic>p</italic>-values) to calculate these values.</p>
</sec>
<sec id="sec009">
<title>2.3 Data extraction</title>
<p>Data extraction was performed independently by two authors (JZ, YB). The data recorded were publication year, daily dose of supplemental CoQ10, study design, intervention duration, country, design details, health status, age and number of participants, side- effects, means and SD data of each parameter before and after the intervention.</p>
</sec>
<sec id="sec010">
<title>2.4 Assessment of risk of bias</title>
<p>The risk of bias (high risk, low risk or unclear risk of bias) was assessed independently with the Cochrane Hand book for Systematic Reviews of Interventions by two reviewers (JZ, CL) for each study[<xref ref-type="bibr" rid="pone.0170172.ref010">10</xref>]. The following methodological domains were considered: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other potential threats to validity.</p>
</sec>
<sec id="sec011">
<title>2.5 Data analysis</title>
<p>Pooled effect size was expressed as weighted mean differences (MD) and corresponding <italic>95% CI</italic> for each parameter in this meta-analysis. The heterogeneity of the included studies was examined by <italic>χ</italic><sup>2</sup> tests and the degree of heterogeneity was estimated using <italic>I</italic><sup>2</sup> statistic. The fixed-effect model (<italic>I</italic><sup><italic>2</italic></sup> was below 50%)[<xref ref-type="bibr" rid="pone.0170172.ref011">11</xref>] or the random-effects model (<italic>I</italic><sup><italic>2</italic></sup> was above 50%)[<xref ref-type="bibr" rid="pone.0170172.ref012">12</xref>] was chosen for meta-analysis of the comparison of each parameter due to CoQ10 treatment compared to that due to placebo. Meta-analysis was performed to determine potential effect modification of variables including age, BMI, dose of CoQ10 supplementation, intervention duration, sample size and the baseline concentration of each parameter. Potential publication bias was explored by using funnel plot, Egger line regression test (Egger’s test) [<xref ref-type="bibr" rid="pone.0170172.ref013">13</xref>] and Begg rank correlation test (Begg’s test) [<xref ref-type="bibr" rid="pone.0170172.ref014">14</xref>]. RevMan software (version 5.2) was used for meta-analysis. Meta-regression analysis, Egger’s test and Begg’s test were performed by STATA software (version 12.0; StatCorp, College Station, TX, USA). <italic>P</italic>&lt; 0.05 was considered as statistically significant. All statistical tests were two-sided.</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>3. Results</title>
<sec id="sec013">
<title>3.1 Description of studies</title>
<p>The initial search identified 619 articles, of which 593 were excluded based on their titles and abstracts. After a full-text review of the remaining 26 potentially relevant articles, 17 articles were further excluded because 4 articles used compound agents other than CoQ10, 6 articles measured an acute effect, 2 articles did not meet a specific RCT design, 2 articles showed incomplete data, 2 articles had non-normally distributed variables and the other one did not provide the exact number of subjects in each intervention and control groups. Finally, Nine papers with RCTs were selected for meta-analysis [<xref ref-type="bibr" rid="pone.0170172.ref015">15</xref>–<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>] (<xref ref-type="fig" rid="pone.0170172.g001">Fig 1</xref>).</p>
<fig id="pone.0170172.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0170172.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram of the study selection process.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0170172.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec014">
<title>3.2 Study characteristics</title>
<p>The characteristics of the included trials were presented in <xref ref-type="table" rid="pone.0170172.t001">Table 1</xref>. Nine trials involving 428 subjects were published from 2009 to 2015, in which five were conducted in Iran[<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0170172.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0170172.ref021">21</xref>–<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>], two in China[<xref ref-type="bibr" rid="pone.0170172.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0170172.ref020">20</xref>], and the other two in Australia[<xref ref-type="bibr" rid="pone.0170172.ref015">15</xref>] and Korea[<xref ref-type="bibr" rid="pone.0170172.ref016">16</xref>], respectively. A parallel, double blinded design was used in all trials [<xref ref-type="bibr" rid="pone.0170172.ref015">15</xref>–<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>], which involved patients with metabolic diseases, including obesity, metabolic syndrome, T2DM, CVD, and NAFLD. The intervention duration lasted from eight to twelve weeks. The daily dose of CoQ10 varied from 100 to 500 mg. All control groups received placebo. Of the nine included studies, three reported plasma CoQ10[<xref ref-type="bibr" rid="pone.0170172.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0170172.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0170172.ref020">20</xref>], TNF-α[<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0170172.ref020">20</xref>], respectively, and four for IL-6[<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0170172.ref021">21</xref>], seven for CRP (three for CRP[<xref ref-type="bibr" rid="pone.0170172.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0170172.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0170172.ref020">20</xref>], four for hs-CRP[<xref ref-type="bibr" rid="pone.0170172.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0170172.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>]).</p>
<table-wrap id="pone.0170172.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0170172.t001</object-id>
<label>Table 1</label> <caption><title>The characteristics of included studies in this study.</title></caption>
<alternatives>
<graphic id="pone.0170172.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0170172.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Study, year</th>
<th align="center"/>
<th align="center">Mori, 2009 [<xref ref-type="bibr" rid="pone.0170172.ref015">15</xref>]</th>
<th align="center">Lee, 2011 [<xref ref-type="bibr" rid="pone.0170172.ref016">16</xref>]</th>
<th align="center">Dai, 2011 [<xref ref-type="bibr" rid="pone.0170172.ref017">17</xref>]</th>
<th align="center">Farsi, 2015 [<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>]</th>
<th align="center">Sanoobar, 2015 [<xref ref-type="bibr" rid="pone.0170172.ref019">19</xref>]</th>
<th align="center">Lee, 2013 [<xref ref-type="bibr" rid="pone.0170172.ref020">20</xref>]</th>
<th align="center">Mohseni, 2015 [<xref ref-type="bibr" rid="pone.0170172.ref021">21</xref>]</th>
<th align="center">Raygan, 2015 [<xref ref-type="bibr" rid="pone.0170172.ref022">22</xref>]</th>
<th align="center">Nesami, 2015 [<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>]</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Country</td>
<td align="center"/>
<td align="center">Australia</td>
<td align="center">Korea</td>
<td align="center">China</td>
<td align="center">Iran</td>
<td align="center">Iran</td>
<td align="center">China</td>
<td align="center">Iran</td>
<td align="center">Iran</td>
<td align="center">Iran</td>
</tr>
<tr>
<td align="center">Duration (weeks)</td>
<td align="center"/>
<td align="center">8</td>
<td align="center">12</td>
<td align="center">8</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center">8</td>
<td align="center">12</td>
</tr>
<tr>
<td align="center">Coenzyme Q10 dose (mg/d)</td>
<td align="center"/>
<td align="center">200</td>
<td align="center">200</td>
<td align="center">300</td>
<td align="center">100</td>
<td align="center">500</td>
<td align="center">300</td>
<td align="center">200</td>
<td align="center">100</td>
<td align="center">100</td>
</tr>
<tr>
<td align="center">Health status</td>
<td align="center"/>
<td align="center">risk of CVD in chronic kidney disease</td>
<td align="center">obesity</td>
<td align="center">coronary artery disease</td>
<td align="center">NAFLD</td>
<td align="center">multiple sclerosis</td>
<td align="center">coronary artery disease</td>
<td align="center">myocardial infarction</td>
<td align="center">metabolic syndrome</td>
<td align="center">hypertension</td>
</tr>
<tr>
<td align="center">Adverse effects</td>
<td align="center"/>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">No</td>
<td align="center">redness, itchiness</td>
<td align="center">NR</td>
<td align="center">No</td>
<td align="center">NR</td>
<td align="center">No</td>
<td align="center">No</td>
</tr>
<tr>
<td align="center" rowspan="2">Age, years</td>
<td align="center">CoQ10</td>
<td align="center">55.4±2.7<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">42.7±11.3<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">67.7±9.4<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">19–54<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td>
<td align="center">33.1± 7.6<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">71.7±11.5<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">60.0±8.0<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">65.9±12.5<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">49.7±5.65<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="center">Placebo</td>
<td align="center">58.6±2.6<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">42.5±11.2<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">70.1±9.8<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">19–54<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td>
<td align="center">30.9± 7.7<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">66.5±11.1<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">61.0±7.0<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">59.9±13.1<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
<td align="center">48.07±6.33<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="center" rowspan="2">Sample size</td>
<td align="center">CoQ10</td>
<td align="center">21</td>
<td align="center">17</td>
<td align="center">28</td>
<td align="center">20</td>
<td align="center">22</td>
<td align="center">23</td>
<td align="center">26</td>
<td align="center">30</td>
<td align="center">30</td>
</tr>
<tr>
<td align="center">Placebo</td>
<td align="center">15</td>
<td align="center">19</td>
<td align="center">28</td>
<td align="center">21</td>
<td align="center">23</td>
<td align="center">19</td>
<td align="center">26</td>
<td align="center">30</td>
<td align="center">30</td>
</tr>
<tr>
<td align="center" rowspan="2">CoQ10,μg/mL (Mean±SD)</td>
<td align="center">CoQ10</td>
<td align="center">NR</td>
<td align="center">0.58±0.24</td>
<td align="center">1.08±0.41</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center">Placebo</td>
<td align="center">NR</td>
<td align="center">0.65±0.27</td>
<td align="center">0.95±0.29</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center" rowspan="2">IL-6, pg/mL (Mean±SD)</td>
<td align="center">CoQ10</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">2.15± 0.98</td>
<td align="center">1.52± 2.4</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">17.7±7.65</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center">Placebo</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">2.19 ± 0.9</td>
<td align="center">1.53± 2.2</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">12.61±5.91</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center" rowspan="2">TNF-α, pg/mL (Mean±SD)</td>
<td align="center">CoQ10</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">1.38 ± 0.71</td>
<td align="center">6.2 ±0.97</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center">Placebo</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">1.27± 0.09</td>
<td align="center">6.09±0.92</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center" rowspan="2">CRP,mg/L (Mean±SD)</td>
<td align="center">CoQ10</td>
<td align="center">1.46±2.87</td>
<td align="center">1.42±1.13</td>
<td align="center">2.29±3.10</td>
<td align="center">18.81 ± 6.96</td>
<td align="center">NR</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">1.51±1.57</td>
<td align="center">3.53 ± 3.36</td>
</tr>
<tr>
<td align="center">Placebo</td>
<td align="center">1.56±2.87</td>
<td align="center">1.04±1.45</td>
<td align="center">1.48±1.82</td>
<td align="center">19.85 ± 9.14</td>
<td align="center">NR</td>
<td align="center">NR<xref ref-type="table-fn" rid="t001fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">2.91±3.05</td>
<td align="center">4.12 ± 3.20</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><italic>Note</italic>: CVD, cardiovascular disease; NAFLD: nonalcoholic fatty liver disease; CoQ10: Coenzyme Q10; IL-6: interleukin-6; TNF-α:tumor necrosis factor-alpha, CRP: C reactive protein; NR, not reported.</p></fn>
<fn id="t001fn002"><p>*the original basic data was not provided and the mean change was replaced;</p></fn>
<fn id="t001fn003"><p><sup>a</sup>, described as Mean±SD;</p></fn>
<fn id="t001fn004"><p><sup>b</sup>, described as minimums and maximums.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>3.3 Risk of bias in the included studies</title>
<p>The assessment of risk of bias was presented in <xref ref-type="fig" rid="pone.0170172.g002">Fig 2</xref>. All studies were randomized trial design, while three trials had[<xref ref-type="bibr" rid="pone.0170172.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0170172.ref019">19</xref>] no detailed information about random sequence generation and six studies[<xref ref-type="bibr" rid="pone.0170172.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0170172.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>] did not describe the methods of allocation concealment. Blinding of participants, personnel and outcome assessment were considered to be unclear in two trials [<xref ref-type="bibr" rid="pone.0170172.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>] and four trials [<xref ref-type="bibr" rid="pone.0170172.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0170172.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0170172.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>], respectively.</p>
<fig id="pone.0170172.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0170172.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Risk of bias assessment of included studies.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0170172.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec016">
<title>3.4 Effects of interventions</title>
<p>The effects of CoQ10 supplementation on the levels of plasma CoQ10, TNF-α, IL-6 and CRP are shown in <xref ref-type="fig" rid="pone.0170172.g003">Fig 3</xref>. The pooled analysis showed that the CoQ10 supplementation group had higher levels of CoQ10 [MD = 1.17, <italic>95% CI</italic> (0.47 to 1.87) μg/ml, <italic>I</italic><sup><italic>2</italic></sup> = 94%] (<xref ref-type="fig" rid="pone.0170172.g003">Fig 3A</xref>) than the control group. Meanwhile, CoQ10 significantly decreased TNF-α level [MD = -0.45, <italic>95% CI</italic> (-0.67 to -0.24) pg/ml, <italic>I</italic><sup>2</sup> = 0%] (<xref ref-type="fig" rid="pone.0170172.g003">Fig 3B</xref>) compared with that of the control group. However, no statistically significant difference was found in the levels of IL-6 [MD = -0.89, <italic>95% CI</italic> (-1.95 to 0.16) pg/ml, <italic>I</italic><sup>2</sup> = 84%] (<xref ref-type="fig" rid="pone.0170172.g003">Fig 3C</xref>) and CRP [MD = -0.21, 95% <italic>CI</italic> (-0.60 to 0.17) mg/L, <italic>I</italic><sup>2</sup> = 21%] (<xref ref-type="fig" rid="pone.0170172.g003">Fig 3D</xref>).</p>
<fig id="pone.0170172.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0170172.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plot of comparisons of Coenzyme Q10 supplementation versus placebo (outcomes: A: serum Coenzyme Q10, B: tumor necrosis factor-alpha, C: interleukin-6, D: C reactive protein).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0170172.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>3.5 Heterogeneity analysis</title>
<p>A univariate meta-regression analysis was conducted to explore the sources of heterogeneity by using age, BMI, dose of CoQ10 supplementation, intervention duration, and sample size and baseline concentration of each parameter. None of these covariates influenced the pooled effect significantly.</p>
</sec>
<sec id="sec018">
<title>3.6 Publication bias</title>
<p>Egger’s test and Begg’s test showed no evidence of publication bias for the included studies on each parameter, which was showed in <xref ref-type="table" rid="pone.0170172.t002">Table 2</xref>. The funnel plots were showed in <xref ref-type="supplementary-material" rid="pone.0170172.s002">S1 Fig</xref>.</p>
<table-wrap id="pone.0170172.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0170172.t002</object-id>
<label>Table 2</label> <caption><title>The results of publication bias.</title></caption>
<alternatives>
<graphic id="pone.0170172.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0170172.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">Parameters</th>
<th align="center" colspan="2">Egger’s test</th>
<th align="center" colspan="2">Begg’s test</th>
</tr>
<tr>
<th align="left"><italic>t</italic> value</th>
<th align="left"><italic>p</italic> value</th>
<th align="left"><italic>z</italic> value</th>
<th align="left"><italic>p</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">CoQ10</td>
<td align="char" char=".">1.00</td>
<td align="char" char=".">0.50</td>
<td align="char" char=".">1.57</td>
<td align="char" char=".">0.12</td>
</tr>
<tr>
<td align="left">IL-6</td>
<td align="char" char=".">-1.43</td>
<td align="char" char=".">0.29</td>
<td align="char" char=".">-0.68</td>
<td align="char" char=".">0.50</td>
</tr>
<tr>
<td align="left">TNF-α</td>
<td align="char" char=".">-0.83</td>
<td align="char" char=".">0.56</td>
<td align="char" char=".">-0.52</td>
<td align="char" char=".">0.60</td>
</tr>
<tr>
<td align="left">CRP</td>
<td align="char" char=".">-0.75</td>
<td align="char" char=".">0.49</td>
<td align="char" char=".">-0.75</td>
<td align="char" char=".">0.45</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec019">
<title>3.7 Side-effects</title>
<p>Five of nine trials provided information on side-effects[<xref ref-type="bibr" rid="pone.0170172.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0170172.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0170172.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>]. Among them, only one trial reported that 2 patients from the CoQ10 group has the minor adverse effects of redness and itchiness of the skin during the study[<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>].</p>
</sec>
</sec>
<sec id="sec020">
<title>4. Discussions</title>
<p>In this systematic review and meta-analysis, we summarized published evidence from nine RCTs that investigated the effects of CoQ10 supplementation on systematic inflammation markers as measured by pro-inflammatory factors (IL-6, TNF-α, CRP). The main finding of the review was that the serum level of CoQ10 were significantly improved and TNF-α level was significantly decreased in CoQ10 supplementation group compared with placebo group in patients with metabolic diseases. However, CoQ10 supplementation did not significantly decreased CRP and IL-6 level.</p>
<p>Adipocytokines are a variety of bioactive molecules (including IL-6, TNF-α) produced and secreted by adipose and other tissues[<xref ref-type="bibr" rid="pone.0170172.ref024">24</xref>]. CRP is a sensitive and dynamic systemic marker of inflammation synthesized in the liver[<xref ref-type="bibr" rid="pone.0170172.ref025">25</xref>]. Increased level of IL-6, TNF-α and CRP are thought to contribute to the development of insulin resistance, T2DM, and CVD[<xref ref-type="bibr" rid="pone.0170172.ref024">24</xref>]. CoQ10, a well-accepted nutritional supplement and anti-oxidant agent, was known to play a protective role in various physiological and pathological processes. So far several studies have identified the anti-inflammatory function of CoQ10[<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0170172.ref026">26</xref>]. However, it remains unclear what is their mechanism of action. Several potential mechanisms might partially explain it. It seems that CoQ10 might play a potential role in decreasing the production of pro-inflammatory cytokines by inhibiting NF-κB gene expression[<xref ref-type="bibr" rid="pone.0170172.ref027">27</xref>], attenuating miR-146a and IL-1 receptor associated kinase modulation[<xref ref-type="bibr" rid="pone.0170172.ref028">28</xref>] and reducing the secretion of macrophage inflammatory protein-1 alpha and regulated upon activation normal T-cell expressed and secreted factors[<xref ref-type="bibr" rid="pone.0170172.ref029">29</xref>]. In addition, several studies observed a negative relationship between adiponectin and inflammatory factors (TNF-α, IL-6, hs-CRP) [<xref ref-type="bibr" rid="pone.0170172.ref030">30</xref>,<xref ref-type="bibr" rid="pone.0170172.ref031">31</xref>]. Zhou et.al reported adiponectin can inhibit stimulated monocytes secreting TNF-α [<xref ref-type="bibr" rid="pone.0170172.ref031">31</xref>]. So it is likely that rise in adiponectin by using of coenzyme Q10[<xref ref-type="bibr" rid="pone.0170172.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0170172.ref023">23</xref>] can indirectly bring about a plunge in inflammatory factors such as TNF-α.</p>
<p>No effect of CoQ10 supplementation on CRP and IL-6 was found in this systematic review. The associations of CRP, IL-6 and CoQ10 serum concentration were influenced by age, sex, BMI, lipoprotein concentration and health status [<xref ref-type="bibr" rid="pone.0170172.ref032">32</xref>,<xref ref-type="bibr" rid="pone.0170172.ref033">33</xref>]. Although the sources of heterogeneity was explored with none covariates influenced the pooled effect, the impact of different conditions with none measured parameters from the subjects on the effect of CoQ10 intervention should not be ruled out. Moreover, the short intervention period, the different dose for intervention and the limited number of participants enrolled in the RCTs may have contributed to the observed null effect of CoQ10 on the serum level of CRP and IL-6.</p>
<p>Several limitations should be acknowledged. Firstly, the present meta-analysis focused only on papers published in English, the ones that reported in other languages may affect the present results. Secondly, most of subjects included in our meta-analysis (eight of nine studies) came from Iran, China and Korea. So the results may be only applicable to the Asian population. Thirdly, although evidence from Egger’s and Begg’s test suggested that publication bias was unlikely, the number of included studies was somewhat small. Finally, because of the limited number of included RCTs, the subgroup analyses were not conducted in this paper. Further rigorously designed RCTs with larger sample sizes and long enough duration are needed to confirm the effectiveness of CoQ10 supplementation for specified metabolic diseases.</p>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>5. Conclusion</title>
<p>The present systematic review provides some evidence that CoQ10 supplementation may partly improve the process of inflammatory state in patients with metabolic diseases. However, the results should be interpreted with caution because of the evidence of heterogeneity. Further studies, especially with larger sample size and well-designed RCTs, are needed to confirm the effectiveness of CoQ10 supplementation on benefitting to inflammation status in metabolic diseases.</p>
</sec>
<sec id="sec022">
<title>Supporting Information</title>
<supplementary-material id="pone.0170172.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0170172.s001" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0170172.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0170172.s002" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Funnel plot for publication bias of Coenzyme Q10 supplementation and serum lipids (outcomes: A: serum Coenzyme Q10, B: tumor necrosis factor-alpha, C: interleukin-6, D: C reactive protein).</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0170172.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawano</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Arora</surname> <given-names>R</given-names></name>. <article-title>The role of adiponectin in obesity, diabetes, and cardiovascular disease</article-title>. <source>J Cardiometab Syndr</source>. <year>2009</year>; <volume>4</volume>(<issue>1</issue>): <fpage>44</fpage>–<lpage>49</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1559-4572.2008.00030.x" xlink:type="simple">10.1111/j.1559-4572.2008.00030.x</ext-link></comment> <object-id pub-id-type="pmid">19245516</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pradhan</surname> <given-names>A</given-names></name>. <article-title>Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders</article-title>. <source>Nutr Rev</source>. <year>2007</year>; <volume>65</volume>(<issue>12 pt 2</issue>): <fpage>S152</fpage>–<lpage>156</lpage>. <object-id pub-id-type="pmid">18240540</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guarner</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Rubio-Ruiz</surname> <given-names>ME</given-names></name>. <article-title>Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease</article-title>. <source>Interdiscip Top Gerontol</source>. <year>2015</year>; <volume>40</volume>: <fpage>99</fpage>–<lpage>106</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000364934" xlink:type="simple">10.1159/000364934</ext-link></comment> <object-id pub-id-type="pmid">25341516</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Basaranoglu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ormeci</surname> <given-names>N</given-names></name>. <article-title>Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management</article-title>. <source>Turk J Gastroenterol</source>. <year>2014</year>; <volume>25</volume>(<issue>2</issue>): <fpage>127</fpage>–<lpage>132</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5152/tjg.2014.7675" xlink:type="simple">10.5152/tjg.2014.7675</ext-link></comment> <object-id pub-id-type="pmid">25003670</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Esser</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Paquot</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Scheen</surname> <given-names>AJ</given-names></name>. <article-title>Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease</article-title>. <source>Expert Opin Investig Drugs</source>. <year>2015</year>; <volume>24</volume>(<issue>3</issue>): <fpage>283</fpage>–<lpage>307</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1517/13543784.2015.974804" xlink:type="simple">10.1517/13543784.2015.974804</ext-link></comment> <object-id pub-id-type="pmid">25345753</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crane</surname> <given-names>FL</given-names></name>. <article-title>Biochemical functions of coenzyme Q(10)</article-title>. <source>Journal of the American College of Nutrition</source>. <year>2001</year>; <volume>20</volume>(<issue>6</issue>): <fpage>591</fpage>–<lpage>598</lpage>. <object-id pub-id-type="pmid">11771674</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Groneberg</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Kindermann</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Althammer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Klapper</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Vormann</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Littarru</surname> <given-names>GP</given-names></name>, <etal>et al</etal>. <article-title>Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2005</year>; <volume>37</volume>(<issue>6</issue>): <fpage>1208</fpage>–<lpage>1218</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.biocel.2004.11.017" xlink:type="simple">10.1016/j.biocel.2004.11.017</ext-link></comment> <object-id pub-id-type="pmid">15778085</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sohet</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Neyrinck</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Pachikian</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>de Backer</surname> <given-names>FC</given-names></name>, <name name-style="western"><surname>Bindels</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Niklowitz</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice</article-title>. <source>Biochem Pharmacol</source>. <year>2009</year>; <volume>78</volume>(<issue>11</issue>): <fpage>1391</fpage>–<lpage>1400</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bcp.2009.07.008" xlink:type="simple">10.1016/j.bcp.2009.07.008</ext-link></comment> <object-id pub-id-type="pmid">19632207</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kunitomo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yamaguchi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kagota</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Otsubo</surname> <given-names>K</given-names></name>. <article-title>Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome</article-title>. <source>J Pharmacol Sci</source>. <year>2008</year>; <volume>107</volume>(<issue>2</issue>): <fpage>128</fpage>–<lpage>137</lpage>. <object-id pub-id-type="pmid">18544898</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref010"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Higgins, JG. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. In.2001; <ext-link ext-link-type="uri" xlink:href="http://www.cochrane-handbook.org" xlink:type="simple">www.cochrane-handbook.org</ext-link>:. The Cochrane Collaboration.</mixed-citation></ref>
<ref id="pone.0170172.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname> <given-names>W</given-names></name>. <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source>. <year>1959</year>; <volume>22</volume>(<issue>4</issue>): <fpage>719</fpage>–<lpage>748</lpage>. <object-id pub-id-type="pmid">13655060</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>. <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source>. <year>1986</year>; <volume>7</volume>(<issue>3</issue>): <fpage>177</fpage>–<lpage>188</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>; <volume>315</volume>(<issue>7109</issue>): <fpage>629</fpage>–<lpage>634</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>; <volume>50</volume>(<issue>4</issue>): <fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mori</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Burke</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Puddey</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Irish</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cowpland</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Beilin</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial</article-title>. <source>J Hypertens</source>. <year>2009</year>; <volume>27</volume>(<issue>9</issue>): <fpage>1863</fpage>–<lpage>1872</lpage>. <object-id pub-id-type="pmid">19705518</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>DC</given-names></name>. <article-title>Effects of coenzyme Q10 on arterial stiffness, metabolic parameters, and fatigue in obese subjects: a double-blind randomized controlled study</article-title>. <source>J Med Food</source>. <year>2011</year>; <volume>14</volume>(<issue>4</issue>): <fpage>386</fpage>–<lpage>390</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/jmf.2010.1202" xlink:type="simple">10.1089/jmf.2010.1202</ext-link></comment> <object-id pub-id-type="pmid">21370966</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dai</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Luk</surname> <given-names>TH</given-names></name>, <name name-style="western"><surname>Yiu</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yip</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SW</given-names></name>, <etal>et al</etal>. <article-title>Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial</article-title>. <source>Atherosclerosis</source>. <year>2011</year>; <volume>216</volume>(<issue>2</issue>): <fpage>395</fpage>–<lpage>401</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.atherosclerosis.2011.02.013" xlink:type="simple">10.1016/j.atherosclerosis.2011.02.013</ext-link></comment> <object-id pub-id-type="pmid">21388622</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farsi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Mohammadshahi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Alavinejad</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rezazadeh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Zarei</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Engali</surname> <given-names>KA</given-names></name>, <article-title>Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial</article-title>. <source>J Am Coll Nutr</source>. <year>2016</year>; <volume>35</volume>(<issue>4</issue>): <fpage>346</fpage>–<lpage>353</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/07315724.2015.1021057" xlink:type="simple">10.1080/07315724.2015.1021057</ext-link></comment> <object-id pub-id-type="pmid">26156412</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sanoobar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eghtesadi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Azimi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Khalili</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Khodadadi</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Jazayeri</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial</article-title>. <source>Nutr Neurosci</source>. <year>2015</year>; <volume>18</volume>(<issue>4</issue>): <fpage>169</fpage>–<lpage>176</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1179/1476830513Y.0000000106" xlink:type="simple">10.1179/1476830513Y.0000000106</ext-link></comment> <object-id pub-id-type="pmid">24621064</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Tseng</surname> <given-names>YF</given-names></name>, <name name-style="western"><surname>Yen</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>PT</given-names></name>. <article-title>Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial</article-title>. <source>Nutr J</source>. <year>2013</year>; <volume>12</volume>(<issue>1</issue>): <fpage>142</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1475-2891-12-142" xlink:type="simple">10.1186/1475-2891-12-142</ext-link></comment> <object-id pub-id-type="pmid">24192015</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mohseni</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Vafa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zarrati</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shidfar</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hajimiresmail</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Rahimi Forushani</surname> <given-names>A</given-names></name>. <article-title>Beneficial Effects of Coenzyme Q10 Supplementation on Lipid Profile and Intereukin-6 and Intercellular Adhesion Molecule-1 Reduction, Preliminary Results of a Double-blind Trial in Acute Myocardial Infarction</article-title>. <source>Int J Prev Med</source>. <year>2015</year>; <volume>6</volume>: <fpage>73</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4103/2008-7802.162461" xlink:type="simple">10.4103/2008-7802.162461</ext-link></comment> <object-id pub-id-type="pmid">26330989</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raygan</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Rezavandi</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Dadkhah Tehrani</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Farrokhian</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Asemi</surname> <given-names>Z</given-names></name>. <article-title>The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome</article-title>. <source>Eur J Nutr</source>. <year>2015</year>; <volume>55</volume>(<issue>8</issue>):<fpage>1</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="pone.0170172.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nesami</surname> <given-names>BN</given-names></name>, <name name-style="western"><surname>Mozaffari-Khosravi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Najarzadeh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Salehifar</surname> <given-names>E</given-names></name>. <article-title>The Effect of Coenzyme Q10 Supplementation on Pro-Inflammatory Factors and Adiponectin in Mildly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled Trial</article-title>. <source>Int J Vitam Nutr Res</source>. <year>2015</year>; <volume>85</volume>(<issue>3–4</issue>): <fpage>156</fpage>–<lpage>164</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1024/0300-9831/a000234" xlink:type="simple">10.1024/0300-9831/a000234</ext-link></comment> <object-id pub-id-type="pmid">26780394</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pittas</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Joseph</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Greenberg</surname> <given-names>AS</given-names></name>. <article-title>Adipocytokines and insulin resistance</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2004</year>; <volume>89</volume>(<issue>2</issue>): <fpage>447</fpage>–<lpage>452</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1210/jc.2003-031005" xlink:type="simple">10.1210/jc.2003-031005</ext-link></comment> <object-id pub-id-type="pmid">14764746</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pepys</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Hirschfield</surname> <given-names>GM</given-names></name>. <article-title>C-reactive protein: a critical update</article-title>. <source>J Clin Invest</source>. <year>2003</year>; <volume>111</volume>(<issue>12</issue>): <fpage>1805</fpage>–<lpage>1812</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI18921" xlink:type="simple">10.1172/JCI18921</ext-link></comment> <object-id pub-id-type="pmid">12813013</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>PT</given-names></name>. <article-title>Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease</article-title>. <source>Nutrition</source>. <year>2012</year>; <volume>28</volume>(<issue>7–8</issue>): <fpage>767</fpage>–<lpage>772</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.nut.2011.11.008" xlink:type="simple">10.1016/j.nut.2011.11.008</ext-link></comment> <object-id pub-id-type="pmid">22342390</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmelzer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lindner</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Rimbach</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Niklowitz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Menke</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Döring</surname> <given-names>F</given-names></name>. <article-title>Functions of coenzyme Q10 in inflammation and gene expression</article-title>. <source>Biofactors</source>. <year>2008</year>; <volume>32</volume>(<issue>1–4</issue>): <fpage>179</fpage>–<lpage>183</lpage>. <object-id pub-id-type="pmid">19096114</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Olivieri</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Lazzarini</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Babini</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Prattichizzo</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Rippo</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Tiano</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation</article-title>. <source>Free Radic Biol Med</source>. <year>2013</year>; <volume>63</volume>: <fpage>410</fpage>–<lpage>420</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.freeradbiomed.2013.05.033" xlink:type="simple">10.1016/j.freeradbiomed.2013.05.033</ext-link></comment> <object-id pub-id-type="pmid">23727324</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmelzer</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lorenz</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Rimbach</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Doring</surname> <given-names>F</given-names></name>. <article-title>Influence of Coenzyme Q_{10} on release of pro-inflammatory chemokines in the human monocytic cell line THP-1</article-title>. <source>Biofactors</source>. <year>2007</year>; <volume>31</volume>(<issue>3–4</issue>): <fpage>211</fpage>–<lpage>217</lpage>. <object-id pub-id-type="pmid">18997284</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Engeli</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Feldpausch</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gorzelniak</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hartwig</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Heintze</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Janke</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Association between adiponectin and mediators of inflammation in obese women</article-title>. <source>Diabetes</source>. <year>2003</year>; <volume>52</volume>(<issue>4</issue>): <fpage>942</fpage>–<lpage>947</lpage>. <object-id pub-id-type="pmid">12663465</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease</article-title>. <source>Cardiovasc Diabetol</source>. <year>2011</year>; <volume>10</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>9</lpage>: <fpage>2</fpage>.</mixed-citation></ref>
<ref id="pone.0170172.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fischer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Onur</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Niklowitz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Menke</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Laudes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Döring</surname> <given-names>F</given-names></name>. <article-title>Coenzyme Q10 redox state predicts the concentration of c-reactive protein in a large caucasian cohort</article-title>. <source>Biofactors</source>. <year>2016</year>; <volume>42</volume>(<issue>3</issue>): <fpage>268</fpage>–<lpage>276</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/biof.1269" xlink:type="simple">10.1002/biof.1269</ext-link></comment> <object-id pub-id-type="pmid">26910885</object-id></mixed-citation></ref>
<ref id="pone.0170172.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niklowitz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Onur</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Fischer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Laudes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Palussen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Menke</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration</article-title>. <source>J Clin Biochem Nutr</source>. <year>2016</year>; <volume>58</volume>(<issue>3</issue>): <fpage>240</fpage>–<lpage>245</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3164/jcbn.15-73" xlink:type="simple">10.3164/jcbn.15-73</ext-link></comment> <object-id pub-id-type="pmid">27257350</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>